BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 22127631)

  • 1. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].
    Ambroziak U; Bednarczuk T; Ginalska-Malinowska M; Małunowicz EM; Grzechocińska B; Kamiński P; Bablok L; Przedlacki J; Bar-Andziak E
    Endokrynol Pol; 2010; 61 Suppl 1():7-21. PubMed ID: 22127631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - management in adults.
    Ambroziak U; Bednarczuk T; Ginalska-Malinowska M; Małunowicz EM; Grzechocińska B; Kamiński P; Bablok L; Przedlacki J; Bar-Andziak E
    Endokrynol Pol; 2010; 61(1):142-55. PubMed ID: 20205117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term morbidity in congenital adrenal hyperplasia].
    Tschaidse L; Quitter F; Hübner A; Reisch N
    Internist (Berl); 2022 Jan; 63(1):43-50. PubMed ID: 34978615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
    Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17-Hydroxyprogesterone in children, adolescents and adults.
    Honour JW
    Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Congenital adrenal hyperplasia].
    Stanić M; Nesović M
    Med Pregl; 1999; 52(11-12):447-54. PubMed ID: 10748766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
    Auer MK; Krumbholz A; Bidlingmaier M; Thieme D; Reisch N
    Neuroendocrinology; 2020; 110(11-12):938-949. PubMed ID: 31711056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Merke DP; Bornstein SR; Avila NA; Chrousos GP
    Ann Intern Med; 2002 Feb; 136(4):320-34. PubMed ID: 11848730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-classical congenital adrenal hyperplasia.
    Dacou-Voutetakis C; Dracopoulou M
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():195-7. PubMed ID: 16641859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of classical congenital adrenal hyperplasia.
    Marumudi E; Khadgawat R; Surana V; Shabir I; Joseph A; Ammini AC
    Steroids; 2013 Aug; 78(8):741-6. PubMed ID: 23624029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Körner A; Kiess W; Kratzsch J; Dörr HG
    Acta Paediatr; 2009 May; 98(5):885-91. PubMed ID: 19236311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia.
    El-Maouche D; Merke DP; Vogiatzi MG; Chang AY; Turcu AF; Joyal EG; Lin VH; Weintraub L; Plaunt MR; Mohideen P; Auchus RJ
    J Clin Endocrinol Metab; 2020 Aug; 105(8):2771-8. PubMed ID: 32589738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term consequences of childhood-onset congenital adrenal hyperplasia.
    White PC; Speiser PW
    Best Pract Res Clin Endocrinol Metab; 2002 Jun; 16(2):273-88. PubMed ID: 12064893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia.
    Schernthaner-Reiter MH; Baumgartner-Parzer S; Egarter HC; Krebs M; Kautzky-Willer A; Kirchheiner K; Luger A; Bayerle-Eder M
    J Sex Med; 2019 Oct; 16(10):1529-1540. PubMed ID: 31447379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort.
    Krone N; Rose IT; Willis DS; Hodson J; Wild SH; Doherty EJ; Hahner S; Parajes S; Stimson RH; Han TS; Carroll PV; Conway GS; Walker BR; MacDonald F; Ross RJ; Arlt W;
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E346-54. PubMed ID: 23337727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contemporary diagnosis and therapy in women with congenital adrenal hyperplasia].
    Maciejewska-Jeske M; Meczekalski B
    Pol Merkur Lekarski; 2013 Nov; 35(209):297-9. PubMed ID: 24575652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
    Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY
    J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 37.